LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,430,000 | -1.5% | 991,818 | +18.5% | 0.08% | +8.7% |
| Q2 2023 | $60,360,000 | +0.3% | 837,170 | +2.3% | 0.07% | -2.8% |
| Q1 2023 | $60,170,739 | +12.5% | 817,983 | +2.2% | 0.07% | +12.7% |
| Q4 2022 | $53,479,753 | -21.8% | 800,596 | +0.9% | 0.06% | -25.0% |
| Q3 2022 | $68,347,000 | -2.3% | 793,621 | +1.2% | 0.08% | +6.3% |
| Q2 2022 | $69,941,000 | -18.1% | 783,924 | +3.3% | 0.08% | +21.5% |
| Q1 2022 | $85,351,000 | -11.6% | 758,741 | +21.4% | 0.06% | -18.8% |
| Q4 2021 | $96,532,000 | +7.5% | 624,969 | -3.1% | 0.08% | +3.9% |
| Q3 2021 | $89,831,000 | +15.3% | 644,778 | +8.6% | 0.08% | +20.3% |
| Q2 2021 | $77,888,000 | +5.5% | 593,698 | +22.6% | 0.06% | -38.5% |
| Q1 2021 | $73,840,000 | -17.0% | 484,358 | -45.9% | 0.10% | -20.0% |
| Q4 2020 | $88,975,000 | +23.4% | 894,678 | +18.3% | 0.13% | +6.6% |
| Q3 2020 | $72,074,000 | -13.2% | 756,133 | +1.9% | 0.12% | -14.7% |
| Q2 2020 | $82,999,000 | +64.7% | 742,053 | +7.1% | 0.14% | +37.5% |
| Q1 2020 | $50,402,000 | -24.4% | 693,085 | +8.4% | 0.10% | +9.5% |
| Q4 2019 | $66,669,000 | +19.6% | 639,265 | +14.2% | 0.10% | +2.2% |
| Q3 2019 | $55,739,000 | -69.0% | 559,965 | -64.5% | 0.09% | -8.8% |
| Q2 2019 | $180,072,000 | +191.9% | 1,577,511 | +221.4% | 0.10% | -2.9% |
| Q1 2019 | $61,697,000 | +3.4% | 490,782 | +11.6% | 0.10% | -8.7% |
| Q4 2018 | $59,652,000 | -41.9% | 439,587 | +17.6% | 0.12% | -31.1% |
| Q3 2018 | $102,625,000 | +24.7% | 373,875 | -5.9% | 0.17% | +17.6% |
| Q2 2018 | $82,270,000 | +28.7% | 397,113 | +2.6% | 0.14% | +21.4% |
| Q1 2018 | $63,941,000 | +26.6% | 387,143 | +5.0% | 0.12% | +31.5% |
| Q4 2017 | $50,489,000 | -19.9% | 368,723 | -20.4% | 0.09% | -21.2% |
| Q3 2017 | $63,042,000 | +10.2% | 463,035 | -1.7% | 0.11% | +7.6% |
| Q2 2017 | $57,186,000 | +46.0% | 471,058 | +27.3% | 0.10% | +47.9% |
| Q1 2017 | $39,159,000 | +17.1% | 369,985 | +12.4% | 0.07% | +10.9% |
| Q4 2016 | $33,446,000 | +20.0% | 329,165 | +20.5% | 0.06% | +18.5% |
| Q3 2016 | $27,875,000 | -58.5% | 273,125 | -51.5% | 0.05% | -18.2% |
| Q2 2016 | $67,180,000 | +131.6% | 563,258 | +107.9% | 0.07% | +13.8% |
| Q1 2016 | $29,012,000 | +15.2% | 270,913 | +16.6% | 0.06% | +11.5% |
| Q4 2015 | $25,192,000 | +14.5% | 232,356 | -9.5% | 0.05% | +10.6% |
| Q3 2015 | $22,001,000 | 0.0% | 256,869 | +17.8% | 0.05% | +6.8% |
| Q2 2015 | $22,001,000 | +24.0% | 218,044 | -5.2% | 0.04% | +25.7% |
| Q1 2015 | $17,745,000 | +143.7% | 230,124 | +68.1% | 0.04% | +133.3% |
| Q4 2014 | $7,282,000 | +158.3% | 136,860 | +128.1% | 0.02% | +150.0% |
| Q3 2014 | $2,819,000 | -24.6% | 60,000 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $3,737,000 | -7.4% | 60,000 | 0.0% | 0.01% | +14.3% |
| Q1 2014 | $4,036,000 | +27.9% | 60,000 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $3,156,000 | -34.1% | 60,000 | -45.8% | 0.01% | -33.3% |
| Q3 2013 | $4,791,000 | +2.4% | 110,700 | -11.4% | 0.01% | -10.0% |
| Q2 2013 | $4,678,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |